Jessica Gill1, Maja Mustapic2, Ramon Diaz-Arrastia3, Rael Lange4, Seema Gulyani2, Tom Diehl2, Vida Motamedi1, Nicole Osier1, Robert A Stern5, Dimitrios Kapogiannis2. 1. a Tissue Injury Branch, National Institutes of Health, National Institute of Nursing Research , Bethesda , MD , United States. 2. b Aging, National Institutes of Health, National Institute of Aging , Baltimore , MD , United States. 3. c Department of Neurology, School of Medicine , University of Pennsylvania , Philadelphia , PA , United States. 4. d Defense and Veterans Brain Injury Center , Walter Reed National Military Medical Center , Bethesda , MD , United States. 5. e Neurosurgery, and Anatomy & Neurobiology , Boston University, Boston University Alzheimer's Disease and CTE Center , Boston , MA , United States.
Abstract
OBJECTIVE: Identify biomarkers in peripheral blood that relate to chronic post-concussive and behavioural symptoms following traumatic brain injuries (TBIs) to ultimately improve clinical management. RESEARCH DESIGN: We compared military personnel with mild TBIs (mTBIs) (n = 42) to those without TBIs (n = 22) in concentrations of tau, amyloid-beta (Aβ42) and cytokines (tumour necrosis factor alpha (TNFα, interleukin (IL)-6 and -10) in neuronal-derived exosomes from the peripheral blood. We utilized nanosight technology coupled with ultra-sensitivity immunoassay methods. We also examined the impact of post-concussive and behavioural symptoms including depression and post-traumatic stress disorder (PTSD) on these neuronal-derived markers. RESULTS: We report that concentrations of exosomal tau (F1, 62 = 10.50), Aβ42 (F1, 61 = 5.32) and IL-10 (F1, 59 = 4.32) were elevated in the mTBI group compared to the controls. Within the mTBI group, regression models show that post-concussive symptoms were most related to exosomal tau elevations, whereas exosomal IL-10 levels were related to PTSD symptoms. CONCLUSIONS: These findings suggest that chronic post-concussive symptoms following an mTBI relate to altered exosomal activity, and that greater tau pathology may underlie chronic post-concussive symptoms that develop following mTBIs. It also suggests that central inflammatory activity contributes to PTSD symptoms following an mTBI, providing necessary insights into the role of inflammation in chronic PTSD symptoms.
OBJECTIVE: Identify biomarkers in peripheral blood that relate to chronic post-concussive and behavioural symptoms following traumatic brain injuries (TBIs) to ultimately improve clinical management. RESEARCH DESIGN: We compared military personnel with mild TBIs (mTBIs) (n = 42) to those without TBIs (n = 22) in concentrations of tau, amyloid-beta (Aβ42) and cytokines (tumour necrosis factor alpha (TNFα, interleukin (IL)-6 and -10) in neuronal-derived exosomes from the peripheral blood. We utilized nanosight technology coupled with ultra-sensitivity immunoassay methods. We also examined the impact of post-concussive and behavioural symptoms including depression and post-traumatic stress disorder (PTSD) on these neuronal-derived markers. RESULTS: We report that concentrations of exosomal tau (F1, 62 = 10.50), Aβ42 (F1, 61 = 5.32) and IL-10 (F1, 59 = 4.32) were elevated in the mTBI group compared to the controls. Within the mTBI group, regression models show that post-concussive symptoms were most related to exosomal tau elevations, whereas exosomal IL-10 levels were related to PTSD symptoms. CONCLUSIONS: These findings suggest that chronic post-concussive symptoms following an mTBI relate to altered exosomal activity, and that greater tau pathology may underlie chronic post-concussive symptoms that develop following mTBIs. It also suggests that central inflammatory activity contributes to PTSD symptoms following an mTBI, providing necessary insights into the role of inflammation in chronic PTSD symptoms.
Authors: Joshua W Gatson; Cari Stebbins; Dana Mathews; Thomas S Harris; Christopher Madden; Hunt Batjer; Ramon Diaz-Arrastia; Joseph P Minei Journal: J Neurosurg Date: 2015-11-27 Impact factor: 5.115
Authors: Heidi Terrio; Lisa A Brenner; Brian J Ivins; John M Cho; Katherine Helmick; Karen Schwab; Katherine Scally; Rick Bretthauer; Deborah Warden Journal: J Head Trauma Rehabil Date: 2009 Jan-Feb Impact factor: 2.710
Authors: Matías Sáenz-Cuesta; Ander Arbelaiz; Amaia Oregi; Haritz Irizar; Iñaki Osorio-Querejeta; Maider Muñoz-Culla; Jesus M Banales; Juan M Falcón-Pérez; Javier Olascoaga; David Otaegui Journal: Front Immunol Date: 2015-02-13 Impact factor: 7.561
Authors: Gregory Scott; Anil F Ramlackhansingh; Paul Edison; Peter Hellyer; James Cole; Mattia Veronese; Rob Leech; Richard J Greenwood; Federico E Turkheimer; Steve M Gentleman; Rolf A Heckemann; Paul M Matthews; David J Brooks; David J Sharp Journal: Neurology Date: 2016-02-03 Impact factor: 9.910
Authors: Sara M Lippa; Ping-Hong Yeh; Jessica Gill; Louis M French; Tracey A Brickell; Rael T Lange Journal: J Neurotrauma Date: 2019-04-09 Impact factor: 5.269
Authors: Cassandra L Pattinson; Jessica M Gill; Sara M Lippa; Tracey A Brickell; Louis M French; Rael T Lange Journal: J Trauma Stress Date: 2019-07-10
Authors: Marlene A Wilson; Israel Liberzon; Merry L Lindsey; Yana Lokshina; Victoria B Risbrough; Renu Sah; Susan K Wood; John B Williamson; Francis G Spinale Journal: Stress Date: 2019-06-04 Impact factor: 3.493
Authors: William R McBride; Caroline E Conlan; Nicole A Barylski; Amelie C Warneryd; Randel L Swanson Journal: Curr Phys Med Rehabil Rep Date: 2022-02-26
Authors: Hanuma Kumar Karnati; Joseph H Garcia; David Tweedie; Robert E Becker; Dimitrios Kapogiannis; Nigel H Greig Journal: J Neurotrauma Date: 2018-10-25 Impact factor: 5.269
Authors: Aditya Vedantam; Jeffrey Brennan; Harvey S Levin; James J McCarthy; Pramod K Dash; John B Redell; Jose-Miguel Yamal; Claudia S Robertson Journal: J Neurotrauma Date: 2020-08-05 Impact factor: 5.269
Authors: David F Tate; Emily L Dennis; John T Adams; Maheen M Adamson; Heather G Belanger; Erin D Bigler; Heather C Bouchard; Alexandra L Clark; Lisa M Delano-Wood; Seth G Disner; Blessen C Eapen; Carol E Franz; Elbert Geuze; Naomi J Goodrich-Hunsaker; Kihwan Han; Jasmeet P Hayes; Sidney R Hinds; Cooper B Hodges; Elizabeth S Hovenden; Andrei Irimia; Kimbra Kenney; Inga K Koerte; William S Kremen; Harvey S Levin; Hannah M Lindsey; Rajendra A Morey; Mary R Newsome; John Ollinger; Mary Jo Pugh; Randall S Scheibel; Martha E Shenton; Danielle R Sullivan; Brian A Taylor; Maya Troyanskaya; Carmen Velez; Benjamin Sc Wade; Xin Wang; Ashley L Ware; Ross Zafonte; Paul M Thompson; Elisabeth A Wilde Journal: Brain Imaging Behav Date: 2021-01-07 Impact factor: 3.978